Loading stock data…
BillionToOne (BLLN)
$120.40+2.23 (+1.89%)
Market ClosedLast close Jun 29
BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics.
Historical Price
Price (Candle)
Synthesizing Whystock Narrative...
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $108.39M↑ | $96.05M↑ | $83.52M↑ | $66.57M↑ | $58.96M |
| Gross Profit | $79.10M↑ | $68.60M↑ | $58.42M↑ | $43.47M↑ | $37.97M |
| Operating Income | $17.83M↑ | $10.33M↑ | $9.63M↑ | -$1.63M↑ | -$2.31M |
| Net Income | $17.97M↑ | $5.98M↑ | $5.71M↑ | -$246,000↑ | -$3.99M |
Peer Comparison
JNJUNHPFE
Fundamentals
BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$4.57B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
5.82%
Volume
Today's trading volume
595,321
Recent News
As SpaceX Slides, This IPO Stock Sparks A Positive Prognosis
As SpaceX stock falters on the launchpad, November IPO BillionToOne shores up support to take aim at new breakout move.
Are Medical Stocks Lagging Biodesix (BDSX) This Year?
Here is how Biodesix, Inc. (BDSX) and BillionToOne (BLLN) have performed compared to their sector so far this year.
Coastal Financial And 2 Additional Stocks Estimated To Be Priced Below Intrinsic Value
Over the last 7 days, the United States market has dropped 3.3%, yet it remains up 22% over the past year with earnings forecasted to grow by 17% annually. In this fluctuating environment, identifying stocks that are potentially priced below their intrinsic value can offer opportunities for investors seeking long-term growth, such as Coastal Financial and two other noteworthy companies.
3 Stocks Conceivably Trading At Discounts Of Up To 49.6%
Over the last 7 days, the United States market has dropped 3.3%, yet it remains up by 22% over the past year, with earnings expected to grow by 17% annually in the coming years. In this fluctuating environment, identifying stocks that may be trading at a discount can offer investors opportunities to capitalize on potential value gains.
Eli Lilly Leads Medical Stocks To Watch, While Google Finds Support
Eli Lilly leads three health care stocks to watch as the market appears to be rotating into medicals. Google stock is finding key support too.